Hookipa Pharma
January 29, 2024 - by Joey Ramson
$HOOK is the biggest laggard in the Prism MarketView Pharmaceuticals index. Today it was announced that the company plans to cut around 30% of its workforce after Roche ($RHHBY) has terminated their collaboration agreement for oncology drug candidate HB-700.
